InFocus NEW 3D InSightâ„¢ 14 Day Hepatotoxicity Testing Service Long-term, repeat-dose toxicity screening in 3D primary hepatocytes
â€¢ Primary human hepatocyte/Kupffer cell co-culture
â€¢ Repeat-dosing over 14 days with ATP endpoint
â€¢ Proprietary 3D InSightâ„¢ Human Liver Microtissues
â€¢ Convenient runs the first week of each month
To meet increased demand for testing in our physiologically integrated hepatocyte models, InSphero now offers convenient, cost-effective monthly screening runs in our patent-pending 3D InSightâ„¢ Human Liver Microtissues. Our new 14 Day Hepatotoxicity Testing Service begins the first week of each month at just $990 per compound with no minimum. Test one compound, or test dozens. Weâ€™ll screen them and return data to you three weeks after the first dosing. Reserve space for your compounds in our next run and begin receiving more mechanistically accurate, biologically relevant results.
With the SCREEN Cell3iMager Neo, InSphero now offers the fastest spheroid-optimized bright field imager at a price every lab can afford. In less than 2 minutes per plate, Neo rapidly determines diameter, area, pseudo volume, and circularity of individual spheroids without disrupting spheroid biology.â€y. Compatible with InSphero GravityTRAPâ„¢ ULA Plates and GravityPLUSâ„¢ Hanging Drop 3D System
Learn about the Neo in our updated on-demand webinar 3D202 - Morphological Profiling of 3D Multicellular Tumor Spheroids (MCTS) with the Cell3iMager
Meet InSphero at
TEDD Annual Meeting 2015
In 2010 the co-founders ZHAW and InSphero AG launched the TEDD competence centre with funding from the Gebert-RÃ¼f Foundation (BREF 2010). In the past 5 years the TEDD network has established itself and successfully promoted 3D cell culture activities. Company visits, workshops and symposia with both industrial and academic partners have been organized and several network projects started using the platform. Currently, 8 network projects funded by the Swiss government are running successfully.
This year's meeting will focus on Moving 3D Cell Cultures from Bench to Practice.